About Alencure Biotech
Alencure Biotech is a company based in Mumbai (India). The company has 16 employees as of August 31, 2024. Alencure Biotech offers products and services including Tablets and Injections.
- Headquarter Mumbai, India
- Employees 16 as on 31 Aug, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Alencure Biotech Private Limited
- Date of Incorporation 24 May, 2016
- Jurisdiction Nahan, Himachal Pradesh, India
-
Annual Revenue
$17.54 M (USD)3.61as on Mar 31, 2024
-
Net Profit
$121.99 K (USD)-44.86as on Mar 31, 2024
-
EBITDA
$659.43 K (USD)-12.46as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
16
as on Aug 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alencure Biotech
Alencure Biotech offers a comprehensive portfolio of products and services, including Tablets and Injections.
Tablets are produced as part of the pharmaceutical offerings, focusing on common health issues with adherence to quality standards
Injections are manufactured for various medical applications, ensuring affordability and compliance with global regulations
Funding Insights of Alencure Biotech
Detailed funding history for Alencure Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alencure Biotech
Investment portfolio details for Alencure Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alencure Biotech
Detailed financials for Alencure Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alencure Biotech Comparisons
Peer comparison for Alencure Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alencure Biotech
Detailed competitors of Alencure Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alencure Biotech
Complete news archive for Alencure Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alencure Biotech
Alencure Biotech is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Aug 31, 2024, the latest employee count at Alencure Biotech is 16.
Annual revenue of Alencure Biotech is $17.54M as on Mar 31, 2024.
Alencure Biotech is identified as a key player in the pharmaceutical industry, having been founded in 2015 with a team of over 500 individuals from diverse nationalities. Its operations have expanded through strategic partnerships and innovative product development, resulting in a valuation of USD 25 million. Products such as tablets, injections, and dry syrups are manufactured in WHO and GMP certified facilities, emphasizing affordability and quality to address global health needs. Services including contract manufacturing and exporting are provided to facilitate international distribution, while rigorous quality controls are maintained to meet international standards. This growth is supported by a commitment to scientific innovation and compliance with regulatory requirements.
Alencure Biotech offers Tablets and Injections.